Bulletin
Investor Alert

Perrigo Co. PLC

NYS: PRGO

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Dec 6, 2021, 5:29 p.m.

/zigman2/quotes/201110862/composite

$

37.04

Change

0.00 0.00%

Volume

Volume 32,098

Quotes are delayed by 20 min

/zigman2/quotes/201110862/composite

Today's close

$ 35.79

$ 37.04

Change

+1.25 +3.49%

Day low

Day high

$36.04

$38.04

Open

52 week low

52 week high

$35.34

$50.90

Open

James E. Dillard

Presently, James E. Dillard is Chief Scientific Officer & Executive VP at Perrigo Co. Plc. Mr. Dillard is also on the board of The Richmond Forum.

Mr. Dillard previously occupied the position of Chief Innovations Officer & SVP-Regulatory Affairs at Altria Group, Inc. SVP-Regulatory Administrative Affairs at Altria Client Services, Inc. and Senior VP-Manufacturing, Science & Technology at U.S. Smokeless Tobacco Co. LLC (both are subsidiaries of Altria Group, Inc.), Director-Cardiovascular & Respiratory Devices at US Food & Drug Administration and Director-Biomedical Engineering Department at Tulane University (Louisiana).

James E. Dillard received an undergraduate degree and a graduate degree from Tulane University (Louisiana).

Transactions

Date Shares Transaction Value
03/05/2021 570   Derivative/Non-derivative trans. at $41.04 per share. 23,393
03/05/2021 1,996   Derivative/Non-derivative trans. at $41.04 per share. 81,915
03/05/2021 666   Derivative/Non-derivative trans. at $41.04 per share. 27,333
03/05/2021 2,326   Derivative/Non-derivative trans. at $41.04 per share. 95,459
02/05/2021 1,396   Derivative/Non-derivative trans. at $43.09 per share. 60,154
02/05/2021 4,297   Derivative/Non-derivative trans. at $0 per share. 0
03/06/2020 666   Derivative/Non-derivative trans. at $53.17 per share. 35,412
03/06/2020 2,326   Derivative/Non-derivative trans. at $53.17 per share. 123,673
02/07/2020 1,342   Derivative/Non-derivative trans. at $59.91 per share. 80,400
02/07/2020 4,298   Derivative/Non-derivative trans. at $59.91 per share. 257,493

Officers and Executives

Mr. Murray S. Kessler
President, Chief Executive Officer & Director
Mr. Raymond P. Silcock
CFO, Principal Accounting Officer & Executive VP
Mr. Thomas M. Farrington
Chief Information Officer & Executive VP
Dr. Grainne Quinn
Chief Medical Officer & Executive Vice President
Mr. Adrian Innergård
General Manager-Northern Europe
Ms. Sharon Kochan
EVP, President-RX Pharmaceuticals
Mr. Svend D. Andersen
EVP & President-Consumer Selfcare International
Mr. Ronald C. Janish
Chief Transformation Officer
Mr. James E. Dillard
President-CSCA & Executive Vice President
Mr. Louis K. Cherico
Treasurer & Vice President
Mr. Bradley Joseph
Vice President-Global Investor Relations
Mr. Robert Willis
Chief Human Resources Officer & Executive VP
Mr. Todd W. Kingma
Secretary, Executive VP & General Counsel
Mr. Rolf Allan Classon
Chairman
Ms. Katherine C. Doyle
Independent Director
Mr. Orlando D. Ashford
Independent Director
Mr. Donal M. O'Connor
Independent Director
Mr. Geoffrey M. Parker
Independent Director
Mr. Theodore Rapp Samuels
Independent Director
Mr. Bradley A. Alford
Independent, Director
Mr. Jeffrey B. Kindler
Independent Director
Ms. Adriana Karaboutis
Independent Director
Ms. Erica L. Mann
Independent Director
Trending Tickers
  • /zigman2/quotes/200172674/composite EDSA+102.72%
  • /zigman2/quotes/209901640/composite SPY-1.67%
  • /zigman2/quotes/201343976/composite UVXY+16.31%
  • /zigman2/quotes/221104327/composite LCID+4.83%
  • /zigman2/quotes/214109287/composite SDC-3.13%
X
Powered by StockTwits
Link to MarketWatch's Slice.